Associated Papers
Complementary modes of resistance to EGFR TKI in lung adenocarcinoma through MAPK activation and cellular plasticity.
Zatzman M et al.
Biorxiv : the Preprint Server for Biology, 2025
40654861 (PubMed )
Supplement: media-1.xlsx › Table_S2_-_IMPACT_Mutations
Unraveling melorheostosis: insights into clinical features, diagnosis, and treatment.
Bhattacharyya T
Jbmr Plus, 2025
SMAD3 mutation in LDS3 causes bone fragility by impairing the TGF-β pathway and enhancing osteoclastogenesis.
El-Gazzar A et al.
Bone Reports, 2022
Aberrations in SMAD family of genes among HNSCC patients.
Thariny E et al.
Bioinformation, 2021
Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway.
Kang H et al.
The Journal of Experimental Medicine, 2020
Hide and seek: Somatic SMAD3 mutations in melorheostosis.
Velchev JD et al.
The Journal of Experimental Medicine, 2020
Select a paper to view details